Fas-Cile en es it fr

Fas-Cile Brand names, Fas-Cile Analogs

Fas-Cile Brand Names Mixture

  • No information avaliable

Fas-Cile Chemical_Formula


Fas-Cile RX_link

No information avaliable

Fas-Cile fda sheet

Fas-Cile msds (material safety sheet)

Fas-Cile Synthesis Reference

No information avaliable

Fas-Cile Molecular Weight

309.469 g/mol

Fas-Cile Melting Point

< 25 oC

Fas-Cile H2O Solubility

Soluble as HCl salt

Fas-Cile State


Fas-Cile LogP


Fas-Cile Dosage Forms

Tablets (oral, 1 mg)

Fas-Cile Indication

Used for the symptomatic treatment of parkinsonism.

Fas-Cile Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Fas-Cile Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Fas-Cile side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Fas-Cile Patient Information

Fas-Cile Organisms Affected

Humans and other mammals